Skip to content
← Full study record

NCT03269552 · MORE INFO

Limitations, agreements, and source contact

Carfilzomib With or Without Rituximab in the Treatment of Waldenstrom Macroglobulinemia or Marginal Zone Lymphoma · Source last updated 2020-01-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
Early termination due to low accrual leading to small number of subjects analyzed.
point Of Contact
email
ssmith50@seattlecca.org
organization
University of Washington
phone
206-606-6546
title
Dr. Stephen Smith
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
Early termination due to low accrual leading to small number of subjects analyzed.
point Of Contact
email
ssmith50@seattlecca.org
organization
University of Washington
phone
206-606-6546
title
Dr. Stephen Smith

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice